Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy | Nature Reviews Clinical Oncology
Favorable aspects and potential difficulties foreseen by the EP with... | Download Scientific Diagram
Rigel's fostamatinib successfully meets endpoint in chronic ITP trial
R406 besylate | Syk inhibitor - Active metabolite of Fostamatinib | InvivoGen
Recent advances in the mechanisms and treatment of immune thrombocytopenia - eBioMedicine
Thrombopoietin receptor agonists: ten years later | Haematologica
Frontiers | Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
JCM | Free Full-Text | Emerging Therapies in Immune Thrombocytopenia
Simplified schema of ITP pathogenesis showing the sites of action of... | Download Scientific Diagram
Frontiers | Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
Fostamatinib for persistent/chronic adult immune thrombocytopenia | Immunotherapy
![PDF] Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d711e8e86aeae763b8fc11f910a59ea4140c53c6/6-Figure1-1.png "PDF] Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) | Semantic Scholar")
PDF] Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) | Semantic Scholar
Medicina | Free Full-Text | Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms
Rigel launches Phase II trial to assess fostamatinib for Covid-19
Mechanism of Action | TAVALISSE HCP
Advances in targeted therapy for malignant lymphoma | Signal Transduction and Targeted Therapy
Mechanism of Action | TAVALISSE HCP
Fostamatinib: A Review in Chronic Immune Thrombocytopenia | SpringerLink
g176401moi008.gif
Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs
APS Publications on Twitter: "Platelets and tyrosine kinase inhibitors: clinical features, mechanism of action and effects on physiology - new Review in @AJPCellPhys https://t.co/G9SSGG4Hrq #platelets #articlesinpress https://t.co/oJ0JnJMjho" / Twitter
JCM | Free Full-Text | Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
